Clarivate (NYSE:CLVT - Get Free Report) released its quarterly earnings results on Wednesday. The company reported $0.18 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.18, Briefing.com reports. Clarivate had a negative net margin of 17.33% and a positive return on equity of 8.65%. The business had revenue of $621.40 million for the quarter, compared to analyst estimates of $587.17 million. During the same period in the previous year, the company earned $0.20 earnings per share. The business's revenue for the quarter was down 4.4% on a year-over-year basis. Clarivate updated its FY 2025 guidance to 0.600-0.700 EPS.
Clarivate Stock Performance
NYSE CLVT traded down $0.23 on Friday, reaching $3.62. 6,273,920 shares of the company's stock traded hands, compared to its average volume of 4,100,375. The firm has a market cap of $2.43 billion, a price-to-earnings ratio of -5.84 and a beta of 1.40. The stock has a 50 day moving average price of $4.27 and a 200-day moving average price of $4.31. Clarivate has a fifty-two week low of $3.04 and a fifty-two week high of $7.15. The company has a debt-to-equity ratio of 0.90, a quick ratio of 0.88 and a current ratio of 0.91.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently commented on the stock. Jefferies Financial Group assumed coverage on shares of Clarivate in a research note on Friday, July 18th. They set a "hold" rating and a $4.50 price objective for the company. Wall Street Zen downgraded shares of Clarivate from a "buy" rating to a "hold" rating in a research note on Saturday, June 21st. One equities research analyst has rated the stock with a sell rating and four have issued a hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $4.83.
Get Our Latest Report on Clarivate
Insider Transactions at Clarivate
In related news, insider James Gordon Samson sold 100,000 shares of the business's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $4.53, for a total transaction of $453,000.00. Following the completion of the transaction, the insider directly owned 1,271,103 shares in the company, valued at $5,758,096.59. The trade was a 7.29% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 23.18% of the stock is owned by corporate insiders.
Institutional Investors Weigh In On Clarivate
Several hedge funds have recently modified their holdings of CLVT. Royal Bank of Canada raised its position in shares of Clarivate by 96.2% during the 1st quarter. Royal Bank of Canada now owns 63,630 shares of the company's stock worth $250,000 after purchasing an additional 31,197 shares during the last quarter. AQR Capital Management LLC raised its position in shares of Clarivate by 37.0% during the 1st quarter. AQR Capital Management LLC now owns 451,872 shares of the company's stock worth $1,749,000 after purchasing an additional 122,099 shares during the last quarter. Goldman Sachs Group Inc. raised its position in shares of Clarivate by 15.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 616,250 shares of the company's stock worth $2,422,000 after purchasing an additional 82,768 shares during the last quarter. Millennium Management LLC raised its position in shares of Clarivate by 1,420.4% during the 1st quarter. Millennium Management LLC now owns 1,188,978 shares of the company's stock worth $4,673,000 after purchasing an additional 1,110,774 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Clarivate by 13.1% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,243,683 shares of the company's stock worth $4,888,000 after purchasing an additional 144,462 shares during the last quarter. 85.72% of the stock is owned by hedge funds and other institutional investors.
About Clarivate
(
Get Free Report)
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.
Further Reading

Before you consider Clarivate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clarivate wasn't on the list.
While Clarivate currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.